WallStSmart
VNRX

Volitionrx Ltd

NYSE MKT: VNRX · HEALTHCARE · MEDICAL DEVICES

$2.62
-0.76% today

Updated 2026-04-30

Market cap
$20.92M
P/E ratio
P/S ratio
12.11x
EPS (TTM)
$-4.40
Dividend yield
52W range
$2 – $19
Volume
13.3M

Volitionrx Ltd (VNRX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
Last 4 quarters
Revenue YoY growth
+133.2%
Most recent quarter
EPS YoY growth
+24.3%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-2.7%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-10.7%
2025-11-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-31$-0.05+2.8%$0.19$0.20+5.3%
2025-11-13$-0.05-33.3%$0.37$0.33-10.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.05$-0.05+2.8%$447034.00+133.2%
2025-09-30$-0.04$-0.05-33.3%$627277.00+32.2%
2025-06-30$-0.05$-0.06-28.5%$406688.00+2.8%
2025-03-31$-0.05$-0.06-34.0%$246385.00+43.6%
2024-12-31$-0.05$-0.06-12.6%$191657.00-21.4%
2024-09-30$-0.07$-0.07+0.0%$474522.00+187.2%
2024-06-30$-0.09$-0.08+11.1%$395797.00+83.0%
2024-03-31$-0.11$-0.10+9.1%$171535.00+14.5%
2023-12-31$-0.11$-0.11+0.0%$243973.00
2023-09-30$-0.13$-0.11+15.4%$165211.00
2023-06-30$-0.15$-0.14+6.7%$216310.00
2023-03-31$-0.14$-0.15-7.1%$149808.00

Frequently asked questions

Has Volitionrx Ltd beaten earnings estimates?
Volitionrx Ltd has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports.
How does VNRX stock react to earnings?
VNRX stock has moved an average of -2.7% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Volitionrx Ltd's revenue growth rate?
Volitionrx Ltd reported year-over-year revenue growth of +133.2% in its most recent quarter, with EPS growing +24.3% year-over-year.